Aims & Scope
CNS & Neurological Disorders - Drug Targets aims to cover all the latest and outstanding
developments in medicinal chemistry,
pharmacology, molecular biology, genomics, and biochemistry of contemporary molecular
targets involved in neurological and central nervous system (CNS) disorders, e.g., disease-specific proteins,
receptors, enzymes, and
genes.
CNS & Neurological Disorders - Drug Targets publishes guest-edited thematic issues written by leaders in the
field covering a range of current topics of CNS & neurological drug
targets. The journal also accepts original research articles, letters, reviews, and drug clinical trial
studies for publication.
As the discovery, identification, characterization, and validation of
novel human drug targets for neurological and CNS drug discovery continue to grow, this journal is
essential reading for all pharmaceutical scientists involved in drug discovery
and development.
CNS & Neurological Disorders - Drug Targets is an international,
peer-reviewed journal on all aspects of neurological disorders, published monthly (print
& online) by Bentham Science Publishers.
